Sign In

Shubhendra Thakur

Entrepreneur & Founder

Shubhendra Singh Thakur is the Co-founder and CEO of ErlySign, a biotechnology company founded in 2019.1 ErlySign specializes in developing early-stage and affordable diagnostic solutions for non-invasive cancer detection using saliva samples.1

Shubhendra has expertise in clinical trials and has worked on several innovative projects, including:

  1. "JOLT" - a women's safety wearable device
  2. "Frosty" - a personal cooling gadget
  3. "Tellon" - a campus networking application recognized by Facebook's Fbstart program
  4. "CUROPAL" - a device for early detection of kidney diseases through urine analysis1

Under his leadership, ErlySign aims to launch a set of validated early detection kits for various types of cancer, including oral, lung, breast, colorectal, and pancreatic cancer, using just 5ml of saliva.1 The company's goal is to prevent 10 million lives from cancer in the coming years through early detection.1

Highlights

Erly Sign:Transforming Diagnostic Industry Via Early Stage Detection

Related Questions

What are Shubhendra Thakur's key achievements in clinical trials?
How did Shubhendra Thakur contribute to the development of the "JOLT" wearable?
What is the significance of ErlySign's saliva-based diagnostic test kit?
How does Shubhendra Thakur's work impact preventative healthcare?
What other projects is Shubhendra Thakur currently involved in?
Shubhendra Thakur
Shubhendra Thakur, photo 1
Shubhendra Thakur, photo 2
Add to my network

Location

Nagpur, Maharashtra, India